Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H31O2.Na |
| Molecular Weight | 278.4059 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCCCCCCCCCCCCCCC([O-])=O
InChI
InChIKey=GGXKEBACDBNFAF-UHFFFAOYSA-M
InChI=1S/C16H32O2.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18;/h2-15H2,1H3,(H,17,18);/q;+1/p-1
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H31O2 |
| Molecular Weight | 255.4161 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26393565Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26393565
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Palmitic acid is a saturated fatty acid, the principal constituent of refined palm oil, present in the diet and synthesized endogenously. Palmitic acid is able to activate the orphan G protein-coupled receptor GPR40. Palmitic acid was also a weak ligand of peroxisome proliferator-activated receptor gamma. Palmitic acid is a ligand of lipid chaperones - the fatty acid-binding proteins (FABPs). Dietary palm oil and palmitic acid may play a role in the development of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL4422 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12496284 |
5.3 null [pEC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14717706 |
156.0 µM [Kd] | ||
Target ID: CHEMBL3344 |
|||
Target ID: CHEMBL2083 |
|||
Target ID: CHEMBL3674 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | SURFAXIN Approved UseSURFAXIN is indicated for the prevention of respiratory distress syndrome
(RDS) in premature infants at high risk for RDS. Launch Date2012 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq. | 2001-06-29 |
|
| Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. | 2001-06-22 |
|
| Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. | 2001-06 |
|
| Systemic and regional free fatty acid metabolism in type 2 diabetes. | 2001-06 |
|
| Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. | 2001-05-25 |
|
| [Branched alkanes and other apolar compounds produced by the cyanobacterium Microcoleus vaginatus from the Negev desert]. | 2001-05-19 |
|
| Differential palmitoylation of two mouse glutamate receptor interacting protein 1 forms with different N-terminal sequences. | 2001-05-18 |
|
| Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. | 2001-05-18 |
|
| Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. | 2001-05-15 |
|
| Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. | 2001-05-11 |
|
| Palmitate-induced apoptosis can occur through a ceramide-independent pathway. | 2001-05-04 |
|
| Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. | 2001-05 |
|
| Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. | 2001-05 |
|
| Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. | 2001-05 |
|
| Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. | 2001-05 |
|
| Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox. | 2001-05 |
|
| Imaging of monolayers composed of palmitic acid and lung surfactant protein B. | 2001-05 |
|
| The sites for fatty acylation, phosphorylation and intermolecular disulphide bond formation of influenza C virus CM2 protein. | 2001-05 |
|
| A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes. | 2001-05 |
|
| n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. | 2001-05 |
|
| Plasma membrane localization of palmitoylated tubulin. | 2001-04-27 |
|
| Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. | 2001-04-27 |
|
| Kinetics of the lipase-catalyzed synthesis of glucose esters in acetone. | 2001-04-20 |
|
| Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains. | 2001-04-15 |
|
| Pulmonary surfactant protein SP-B is significantly more immunoreactive in anionic than in zwitterionic bilayers. | 2001-04-13 |
|
| Regulation of surfactant-like particle secretion by Caco-2 cells. | 2001-04-02 |
|
| Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides. | 2001-04-02 |
|
| Fatty acid and triglyceride composition of milk fat from lactating Holstein cows in response to supplemental canola oil. | 2001-04 |
|
| Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice. | 2001-04 |
|
| Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein. | 2001-04 |
|
| Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth. | 2001-04 |
|
| Carotenoid esters in vegetables and fruits: a screening with emphasis on beta-cryptoxanthin esters. | 2001-04 |
|
| Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? | 2001-04 |
|
| Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. | 2001-03-30 |
|
| Regulation of G proteins by covalent modification. | 2001-03-26 |
|
| Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. | 2001-03-15 |
|
| Anaerobic biodegradation of alkanes by enriched consortia under four different reducing conditions. | 2001-03 |
|
| Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth. | 2001-03 |
|
| Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet. | 2001-03 |
|
| Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. | 2001-03 |
|
| Gas chromatographic analysis of total fatty acids in cider. | 2001-03 |
|
| Modelling of hexadecane degradation in continuous-flow cultures. | 2001-03 |
|
| Effects of antiinflammatory triterpenes isolated from Leptadenia hastata latex on keratinocyte proliferation. | 2001-03 |
|
| Participation of carnitine palmitoyltransferase in the synthesis of dipalmitoylphosphatidylcholine in rat alveolar type II cells. | 2001-02 |
|
| A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. | 2001-02 |
|
| Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. | 2001-02 |
|
| Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. | 2001-02 |
|
| Myocardial fatty acid oxidation in patients with impaired glucose tolerance. | 2001-02 |
|
| Effect of fatty acids on phase behavior of hydrated dipalmitoylphosphatidylcholine bilayer: saturated versus unsaturated fatty acids. | 2001-02 |
|
| L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions. | 2001-01 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18710535
The conditioned media from palmitic acid (0.2 mM) treated rat cortical astroglia, but not the cerebellar astroglia, significantly elevated levels of phosphorylated tau and BACE1 in cortical neurons as compared to controls
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:47:54 GMT 2025
by
admin
on
Mon Mar 31 18:47:54 GMT 2025
|
| Record UNII |
JQ43KP6296
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CODEX ALIMENTARIUS (GSFA) |
INS-470(I)
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
||
|
EPA PESTICIDE CODE |
600119
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
||
|
CFR |
21 CFR 186.1771
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
||
|
JECFA EVALUATION |
INS-470(I)
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
JQ43KP6296
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
JQ43KP6296
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
206-988-1
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
DTXSID2041127
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
408-35-5
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
300000054641
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
759
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
1364910
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | RxNorm | ||
|
2735111
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY | |||
|
Sodium palmitate
Created by
admin on Mon Mar 31 18:47:54 GMT 2025 , Edited by admin on Mon Mar 31 18:47:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |